Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
SEQENS is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Canada
Founded:2017
Employees:612
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Europe
Manufacturing Facilities
1 site worldwide
NOVACYL (THAILAND) LIMITED
321 Moo 4, Sukhumvit Road Bangpoo Industrial Estate, MUEANG SAMUT PRAKAN, 10280
Site Capabilities
2 capabilitiesANALYSIS
API MANUFACTURE
Regulatory Approvals
Drug Approval 5FY4YP
FDA · #APR-C8PSH3WX · 2018-09-01
Drug Approval Q1DGD7
EMA · #APR-3TQZCD0B · 2019-09-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-EOMNTJIS
Issued: 2020-10-16
Expires: 2025-03-14
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-15ASS7IX
Issued: 2020-12-20
Expires: 2025-07-18
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-H5NBWFUM
Issued: 2020-04-03
Expires: 2025-07-14
Health Canada GMP
Health Canada
Cert #: CERT-YHKTAQIE
Issued: 2020-06-26
Expires: 2025-11-06
Loading CDMO intelligence...
Key facts about SEQENS
- SEQENS is headquartered in Canada.
- SEQENS was founded in 2017.
- SEQENS has 612 employees.
- SEQENS has one manufacturing site listed on CDMO Hub, in MUEANG SAMUT PRAKAN, Thailand.
- SEQENS's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like SEQENS
Directory pages this company appears in, each with the full list of matching manufacturers.